Crossref
Progress in MRD-Directed Therapy for T-Cell Acute Lymphoblastic Leukemia
Journal of Clinical Personalized Medicine · 2026 · 05 (03) · 240-252
DOI: 10.12677/jcpm.2026.53204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Personalized Medicine, 2026. Verfasst von 子贤 刘. Die Arbeit nennt 70 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
刘, 子. (2026). Progress in MRD-Directed Therapy for T-Cell Acute Lymphoblastic Leukemia. Journal of Clinical Personalized Medicine, 05(03), 240-252. https://doi.org/10.12677/jcpm.2026.53204
Vancouver
刘 子. Progress in MRD-Directed Therapy for T-Cell Acute Lymphoblastic Leukemia. Journal of Clinical Personalized Medicine. 2026;05(03):240-252. doi:10.12677/jcpm.2026.53204
BibTeX
@article{2026,
author = {刘, 子贤},
title = {Progress in MRD-Directed Therapy for T-Cell Acute Lymphoblastic Leukemia},
journal = {Journal of Clinical Personalized Medicine},
year = {2026},
volume = {05},
number = {03},
pages = {240--252},
doi = {10.12677/jcpm.2026.53204}
}
EUVIMED